fbpx
close read more
  • Oncology
  • Cardiometabolism
  • Neuroscience
  • immuno-inflammation

Phase 1

Haematological malignancies

Mcl1 inhibitor

Haematological malignancies

Bcl2 inhibitor

Haematological malignancies

DHODH inhibitor

Haematological malignancies

UCART19

Solid tumors

Anti CD73

Solid tumors

MAT2A combo

Solid tumors

NKG2A

Solid tumors

PDLx41 BB

Solid tumors

Anti PD1xAnti TIM3 combo

Solid tumors

Anti LAG3

Relapsed or refractory myelodysplastic syndrome (MDS)

Tibsovo®

Grade 2-3 Gliome

Vorasidenib, combo

Phase 2

Non Small Cell Lung Cancer

Anti Met

Sjögren disease

Anti IL7R

Phase 3

Colorectal cancer, 3rd line

Lonsurf® combo

Colorectal cancer, 3rd line

Anti EGFR combo Lonsurf®

Acute myeloid leukemia (AML) IC-eligible, 1st line

Tibsovo® combo

Low-grade Glioma

Vorasidenib